ChromaDex (CDXC) Reports In-Line Q2 EPS

ChromaDex (NASDAQ: CDXC) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $17.7 million versus the consensus estimate of $17.16 million. Adjusted EBITDA excluding total legal expense, a non-GAAP measure, was a profit of $0.6 million, a $0.1 million improvement from the prior year quarter.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance